180 related articles for article (PubMed ID: 30949407)
21. β-Catenin/TCF4 Complex-Mediated Induction of the
Aono S; Hatanaka A; Hatanaka A; Gao Y; Hippo Y; Taketo MM; Waku T; Kobayashi A
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31288376
[TBL] [Abstract][Full Text] [Related]
22. Nrf3 promotes UV-induced keratinocyte apoptosis through suppression of cell adhesion.
Siegenthaler B; Defila C; Muzumdar S; Beer HD; Meyer M; Tanner S; Bloch W; Blank V; Schäfer M; Werner S
Cell Death Differ; 2018 Nov; 25(10):1749-1765. PubMed ID: 29487353
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
24. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
25. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
26. [Role of allograft inflammatory factor-1 in regulating the proliferation, migration and apoptosis of colorectal cancer cells].
Ai XL; Yao F; Wang XJ; Duan DB; Li K; Hu ZY; Yin G; Wang M; Wu BY
Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):511-519. PubMed ID: 29891445
[TBL] [Abstract][Full Text] [Related]
27. Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer.
Mora Vidal R; Regufe da Mota S; Hayden A; Markham H; Douglas J; Packham G; Crabb SJ
Urology; 2018 Feb; 112():225.e1-225.e7. PubMed ID: 29154981
[TBL] [Abstract][Full Text] [Related]
28. Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway.
Zhang X; Liu K; Zhang T; Wang Z; Qin X; Jing X; Wu H; Ji X; He Y; Zhao R
Oncotarget; 2017 Jan; 8(1):1541-1554. PubMed ID: 27903975
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-7 Exerts Antiangiogenic Effect on Colorectal Cancer via ERK Signaling.
Fan X; Liu M; Tang H; Leng D; Hu S; Lu R; Wan W; Yuan S
J Surg Res; 2019 Aug; 240():48-59. PubMed ID: 30909065
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK-mediated apoptosis.
Fassetta M; D'Alessandro L; Coltella N; Di Renzo MF; Rasola A
Cell Signal; 2006 Nov; 18(11):1967-76. PubMed ID: 16677802
[TBL] [Abstract][Full Text] [Related]
31. HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.
Feng Y; Xu X; Zhang Y; Ding J; Wang Y; Zhang X; Wu Z; Kang L; Liang Y; Zhou L; Song S; Zhao K; Ye Q
Sci Rep; 2015 Mar; 5():9429. PubMed ID: 25800793
[TBL] [Abstract][Full Text] [Related]
32. Erbin interacts with c-Cbl and promotes tumourigenesis and tumour growth in colorectal cancer by preventing c-Cbl-mediated ubiquitination and down-regulation of EGFR.
Yao S; Zheng P; Wu H; Song LM; Ying XF; Xing C; Li Y; Xiao ZQ; Zhou XN; Shen T; Chen L; Liu YH; Lai MD; Mei L; Gao TM; Li JM
J Pathol; 2015 May; 236(1):65-77. PubMed ID: 25521828
[TBL] [Abstract][Full Text] [Related]
33. Adenomatous polyposis coli determines sensitivity to the EGFR tyrosine kinase inhibitor gefitinib in colorectal cancer cells.
Zhang Y; Xiao Q; Zhang H; Sun X; Ge H; Liu X; Guan L; Sun M
Oncol Rep; 2014 Apr; 31(4):1811-7. PubMed ID: 24573033
[TBL] [Abstract][Full Text] [Related]
34. LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer.
Tang R; Chen J; Tang M; Liao Z; Zhou L; Jiang J; Hu Y; Liao Q; Xiong W; Tang Y; Nie S
Int J Biol Sci; 2019; 15(13):2885-2896. PubMed ID: 31853225
[TBL] [Abstract][Full Text] [Related]
35. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
[TBL] [Abstract][Full Text] [Related]
36. EGFR expression in patients with stage III colorectal cancer after adjuvant chemotherapy and on cancer cell function.
Huang CW; Chen YT; Tsai HL; Yeh YS; Su WC; Ma CJ; Tsai TN; Wang JY
Oncotarget; 2017 Dec; 8(70):114663-114676. PubMed ID: 29383110
[TBL] [Abstract][Full Text] [Related]
37. LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer.
Kou C; Zhou T; Han X; Zhuang H; Qian H
Biochem Biophys Res Commun; 2015 Aug; 464(2):519-25. PubMed ID: 26159916
[TBL] [Abstract][Full Text] [Related]
38. NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5.
Gurri S; Siegenthaler B; Cangkrama M; Restivo G; Huber M; Saliba J; Dummer R; Blank V; Hohl D; Werner S
EMBO Mol Med; 2023 Nov; 15(11):e17761. PubMed ID: 37807968
[TBL] [Abstract][Full Text] [Related]
39. NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K/AKT pathway.
Sun K; Wang S; He J; Xie Y; He Y; Wang Z; Qin L
Oncotarget; 2017 Dec; 8(64):107932-107946. PubMed ID: 29296214
[TBL] [Abstract][Full Text] [Related]
40. GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway.
Yu J; Liu M; Liu H; Zhou L
Mol Cell Biochem; 2019 Jul; 457(1-2):191-199. PubMed ID: 31069596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
